Cristofalo V J, Pignolo R J
Center for Gerontological Research, Medical College of Pennsylvania, Philadelphia.
Physiol Rev. 1993 Jul;73(3):617-38. doi: 10.1152/physrev.1993.73.3.617.
The life history of fibroblast and fibroblast-like cells includes an initial stage of outgrowth and establishment in culture; a period of vigorous proliferation which has a variable length, depending on the tissue of origin, age of the donor, etc.; a period of declining proliferative vigor which includes substantial cell death; and finally, the emergence of an (apparently) long-lived population which is unable to proliferate in response to growth factors. During the phase of declining proliferative vigor, the cells acquire characteristics, some of which are similar to the characteristics of cells in older individuals. Eventually the culture completely loses proliferative capacity. A comparable life history has been described for glial cells, keratinocytes, vascular smooth muscle cells, endothelial cells, and lymphocytes which suggests that this life history is characteristic of those cell types that, in vivo, retain the capacity for proliferation throughout the life span. Numerous studies have shown a correlation between the age of the tissue donor and the replicative life span of the cells in culture. In addition, for a small sample of species, there is a direct correlation between fibroblast replicative life span in vitro and maximum life span potential of the species. The period in the life history that is usually referred to as the "senescent phase" is probably more complicated than was originally thought, since studies with life span modulators suggest that there is a "conditionally" senescent state from which cells can be rescued for one or more additional rounds of DNA synthesis. Finally, the cells enter an "obligatory" arrested state in which only SV40 infection can reverse the block to DNA synthesis but not the block to mitosis. The modern era of aging research in tissue culture is just over 30 years old. The inception of the field really began with the recognition by Hayflick and Moorhead (109) that the phenomenon of senescence in vitro paralleled, in some of its characteristics, cell aging in vivo and thus provided a model that could be used to study the cellular mechanisms underlying senescence in controlled environmental conditions. The research in this area began with a detailed characterization and comparison of young versus senescent cell morphology and physiology. These studies provided the basis for a wide variety of subsequent studies that addressed possible mechanisms underlying cell senescence. These included studies on DNA repair, protein synthetic errors, chromatin structure and function, and mechanisms for modulating replicative life span.(ABSTRACT TRUNCATED AT 400 WORDS)
成纤维细胞和成纤维样细胞的生命历程包括在培养中最初的生长和建立阶段;一段旺盛增殖期,其时长因起源组织、供体年龄等因素而有所不同;一段增殖活力下降期,其中包括大量细胞死亡;最后,出现一个(显然)长寿的细胞群体,该群体无法对生长因子作出增殖反应。在增殖活力下降阶段,细胞获得一些特征,其中一些与老年个体细胞的特征相似。最终,培养物完全丧失增殖能力。神经胶质细胞、角质形成细胞、血管平滑肌细胞、内皮细胞和淋巴细胞也有类似的生命历程,这表明这种生命历程是那些在体内终生保持增殖能力的细胞类型所特有的。大量研究表明组织供体的年龄与培养细胞的复制寿命之间存在关联。此外,对于一小部分物种而言,成纤维细胞在体外的复制寿命与该物种的最大寿命潜力之间存在直接关联。生命历程中通常被称为“衰老期”的阶段可能比最初认为的更为复杂,因为对寿命调节剂的研究表明存在一种“条件性”衰老状态,细胞可以从中被挽救,进行一轮或多轮额外的DNA合成。最后,细胞进入一种“强制性”停滞状态,在此状态下,只有SV40感染才能逆转对DNA合成的阻滞,但不能逆转对有丝分裂的阻滞。组织培养中衰老研究的现代时代刚刚超过30年。该领域的开端实际上始于Hayflick和Moorhead(109)认识到体外衰老现象在某些特征上与体内细胞衰老相似,从而提供了一个可用于在可控环境条件下研究衰老潜在细胞机制的模型。该领域的研究始于对年轻细胞与衰老细胞形态和生理学的详细表征与比较。这些研究为后续大量探讨细胞衰老潜在机制的研究奠定了基础。这些研究包括对DNA修复、蛋白质合成错误、染色质结构与功能以及调节复制寿命机制的研究。(摘要截选至400词)